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Abstract Open partial or total laryngectomies with or without 
radiotherapy (RT) or chemoradiotherapy (CRT) are 
the only mainstays in the treatment of laryngeal carci-
nomas. However, minimally invasive procedures such 
as transoral endoscopic carbondioxide laser microsur-
gery (TLM) or transoral robotic surgeries (TRS) are 
now being increasingly used in selected patients. The 
laryngeal framework is not disturbed in these proce-
dures; therefore, the postoperative swallowing functi-
on improves more rapidly, and routine tracheotomy is 
not usually required. Moreover, they have oncological 
results comparable with open procedures.
Keywords: Laryngeal carcinoma, laser surgery, robotic 
surgery, minimally invasive surgical procedures 
Introduction
For years, total laryngectomy has become the only 
treatment choice for patients with advanced stage 
laryngeal carcinoma. In the last 20 years, import-
ant surgical improvements have been performed 
in protecting the functional integrity of the larynx. 
With the more widespread surgical use of micro-
scope, endoscope, and laser at present, successful 
functional and oncologic results in laryngeal car-
cinoma can be obtained through transoral laser 
microsurgery (TLM) and/or transoral robotic sur-
geries (TRS).
Clinical and Research Impacts
Transoral laser microsurgery is a minimally inva-
sive surgery performed using surgical microscope, 
microsurgical instruments, and surgical carbon di-
oxide (CO2) laser during direct laryngoscopy. In 
1972, Strong and Jako (1) were the first to use CO2 
laser in laryngeal carcinoma surgery.  Although the 
approach of resecting a tumor in pieces rather than 
as en block according to traditional oncologic rules 
arouses suspicion, it is being increasingly used be-
cause it preserves the airway and thus causes less 
damage to swallowing and speech functions (2). 
Compared to radiotherapy (RT) and open partial 
laryngectomy, the advantages of TLM include the 
application in the outpatient status, shorter treat-
ment period, repetition in recurrences, choice of 
RT in second primary tumor and recurrent tumor 
cases, opportunity to perform salvage partial open 
surgery after TLM if needed, and no need of tra-
cheostomy and feeding tube (3).
In TLM, delicate incisions performed with laser 
do not cause unnecessary laryngeal mucosa loss. 
In this way, postoperative speech and swallowing 
functions are preserved at the highest possible lev-
el, and early rehabilitation is enabled. In contrast, 
this situation often leads to positive surgical mar-
gins due to a 1-2 mm fine safety margin. The ef-
fects of this positivity on local control and survival 
are controversial. While some authors recommend 
routine second-look laryngoscopy, the high cost 
and high rate of a tumor-negative surgical speci-
men at the second look even as the first pathology 
margin is positive necessitate questioning this pro-
cedure (4). For solving this problem, Remacle et al. 
(5) have recommended frozen-section biopsy as an 
alternative to second-look laryngoscopy during the 
first surgery. The results of frozen-section biopsy, 
which is taken during transoral laser laryngecto-
my, and those of a routine histopathological exam-
ination are consistent at the rate of approximately 
94% (6). These findings indicate that frozen-section biopsy is a 
safe technique for reaching benign surgical margins. However, 
in the study of Fang et al. (7) on TLM patients, it has been stat-
ed that although negative margins were obtained with repeated 
excisions in the same session in patients whose frozen-section 
results were positive in the first surgery, the rate of recurrent 
tumor development in the first year was higher compared to pa-
tients with negative borders in the first surgery. Authors suggest 
that the follow-up controls of these patients should be conduct-
ed more frequently despite the no need for second-look laryn-
goscopy. A surgeon’s inability to estimate tumor margins exactly 
at the first look and accordingly surgical margin positivity can be 
explained with possible field cancerization or possible submuco-
sal spread beyond the clinically and microscopically identifiable 
tumor. As a result, even if excisions are repeated until negative 
margins are obtained with frozen section biopsy in the first sur-
gery; the situation that has resulted from the invasive behavior 
of tumor negatively affects the survival (7).
In this type of surgeries, the main determinant for a successful 
outcome is the selection of appropriate patients. Carcinoma in 
situ and T1 glottic carcinomas not involving anterior commissure 
constitute the most optimal patient group for this technique (8). 
In early glottic cancers, the addition of “vestibulectomy,” which 
was defined by Kashima et al. (9), to the surgical procedure ex-
pands the view during surgery and also allows better follow-up 
examinations. Patients can be followed up with repeated office 
laryngoscopic examinations in this manner (8). In case of any 
clinical suspect in these follow-ups, control direct laryngoscopy 
and biopsy should be performed. The causes of the clinical suspect 
were defined as newly developed hoarseness, local pain or otalgia, 
a suspicious appearance in the vocal cord in office laryngoscopy, 
or an anatomy preventing the entire vocal cord to be viewed (8).
In early glottic cancers, anterior commissure involvement was 
demonstrated in 37.1% of patients developing local recurrence 
after TLM (10). There is no common approach that is interna-
tionally accepted for glottic cancers developing in the anterior 
commissure or involving it. Although local control success rates 
of open partial laryngectomy are quite high in early glottic tu-
mors with anterior commissure involvement, an important dis-
advantage is that the larynx is blindly entered during surgery 
only from the region preoperatively selected. Until the larynx 
is opened, tumor cannot be viewed (11). In contrast, tumor also 
may not be completely viewed in a single field during TLM, but 
it is still removed with the magnification advantage of a micro-
scope. However, TLM is accepted as contraindicated by many 
surgeons. Nevertheless, some studies have suggested that a safe 
endoscopic surgery can be performed with some modifications 
(11-13). Shapshay et al. (12) reported successful results by using 
endoscopic and external approaches together and including a 
small part of the thyroid cartilage, which encounters with the 
anterior commissure, in specimen. In addition to early spread 
and low rates of local control, poor quality of voice after laser 
excisions in these tumors limits its advantage of use (14). Tay-
lor et al. (15) compared primary treatment approaches of RT 
and TLM in a group of glottic cancer patients with anterior 
commissure involvement (T1b), and they found no significant 
difference between the two groups with regard to voice quality. 
In the oncologic evaluation of results, the rates of two-year local 
control for TLM and RT were found to be 95% and 85.9%, 
respectively; the rates of larynx preservation were 100% and 
85.9%, respectively; and the rates of disease-free survival were 
88.7% and 88.9%, respectively. The authors concluded that 
TLM was at least as effective as RT from the oncologic per-
spective in patients. When TLM is used as a treatment option 
in glottic cancer cases with anterior commissure involvement, a 
planned second-look surgery allows early detection of possible 
recurrences (16).
Hinni et al. (17) conducted a multicentered study on patients 
with five-year follow-up and reported that the larynx was pre-
served at the rate of 92%. This was the first multinational and 
multicentered study in terms of the oncologic results of TLM 
and its practicability. In the series of Peretti et al. (18) on 595 
patients treated with TLM, the rate of five-year disease-specific 
survival was reported as 100% in patients with T1-T3 glottic 
carcinoma and the rate of larynx preservation as 72.7% in T3 
patients. In early-stage glottic cancers, the five-year disease-spe-
cific and general survival rates were approximately 95% and 
80%, respectively (19). Local preservation, organ preservation, 
and survival rates were almost similar in RT, TLM, and open 
partial surgeries (vertical hemilaryngectomy).
Supraglottic cancers are detected in later stages, and their tu-
mor control rates are lower than those of glottic cancers, because 
their tendency to neck metastasis is higher (20). Supraglottic 
open partial laryngectomy is an organ preserving surgery with a 
five-year survival rate of 70%-75% and disease-free survival rate 
of 90% (21). To provide disease control is easier in the primary 
region than in the neck in these tumors. In supraglottic laryn-
gectomy with TLM, two main disadvantages become promi-
nent. The first is the prolonged recovery period developing in 
association with a leaving surgical defect to secondary healing. 
The second is to perform an external surgery due to the need 
for bilateral neck dissection. In tumors that are endoscopical-
ly accessible, while TLM has similar local control and survival 
rates compared to open supraglottic laryngectomy, its functional 
outcomes are more satisfying (22, 23). In addition, when TLM 
is combined with postoperative RT in the neck, it provides high 
rates of local control and survival (88% for three years) (23).
The use of TLM in T1-T2 and carefully selected T3 glottic and 
supraglottic cancers appears oncologically satisfying. An insuffi-
cient view of the surgical site, anterior commissure involvement 
in the craniocaudal direction (T2), invasion of the posterior 
paraglottic space with arytenoid fixation, massive infiltration of 
the pre-epiglottic space, and the presence of minor thyroid car-
tilage erosion (T3) are the most controversial situations with re-
gard to the use of TLM in glottic and supraglottic cancers (24).
The TRS device (Da Vinci robotic surgery system, Intuitive 
Surgical Inc., Sunnyvale, CA, USA) consists of a robotic tower 
including a surgeon console and four movable arms. The sur-
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geon sits on the console including a high-resolution three-di-
mensional monitor and directs the robotic arms. The procedures, 
such as supraglottic laryngectomy, vertical partial laryngectomy, 
cordectomy, and laryngectomy, can be performed through this 
technique. Compared to TLM, TRS allows higher view quality 
and an opportunity to approach the target more easily. Surgical 
instruments articulated at the distal ends of the robotic arms 
provide an advantage of free movements and high degree of tis-
sue manipulation. Nevertheless, the transoral approach creates a 
disadvantage with at least the present laryngoscopes. Particular-
ly, patients with anatomic features, such as narrow mandibular 
arch, anteriorly located larynx, narrow pharynx, and existing and 
complete teeth are inappropriate candidates for TRS (25).
In supraglottic surgeries performed with TLM, the lesion is 
excised not as en block, but in pieces. Moreover, surgeons work 
on a narrow laryngeal field with limited microscopic and laser 
line of sight. It is difficult to work with long instruments. In 
2007, Weinstein et al. (26) published regarding supraglottic 
laryngectomy using the TRS technique. The three-dimension-
al microscopic view and bimanual use of robotic arms allow 
a delicate surgery in a restricted field. In TLM, particularly, 
the excision of pre-epiglottic region is difficult due to limited 
sight. However, TRS provides this region to be safely included 
in specimen as en block (27). Park et al. (27) reported the rate 
of one-year disease-free survival after supraglottic laryngec-
tomy with TRS as 91%, the mean time of transition to oral 
feeding as 8.3 days, the mean length of tracheotomy as 11.2 
days, and the mean length of inpatient treatment as 13.5 days. 
Of the total patients, 90.9% stated voice and swallowing func-
tions to be satisfying. In the TRS series of Kayhan et al. (28) 
on 13 patients with T1-T2 supraglottic cancer, they reported 
that the average blood loss was below 40 mL in addition to 
the advantages of the short length of transition to oral feeding, 
short length of hospitalization, and no need for tracheotomy. 
In literature, local control rates after TRS supraglottic laryn-
gectomy are reported to range between 80% and 100% (29-
32). The robotic approach is used as an alternative to TLM also 
in early-stage glottic cancers (33). Disadvantages of laryngeal 
surgery using TRS are the limited type of surgical instruments, 
high cost, and absence of an optimal retractor for expanding 
the working site (27). Moreover, a large series including long-
term survivals are needed for the oncologic safety.
Total laryngectomy is a treatment approach with proven surgical 
efficiency and results in laryngeal cancers recurring after RT. The 
method that is preferred by considering its safe oncologic results 
regardless of the location or stage of recurring disease is still 
open total laryngectomy in many centers (34). However, this ap-
proach can cause a complete organ or function loss even in very 
small tumors. Surgical developments for the protection of func-
tion have led to questioning the usability of more conservative 
approaches also in recurring cases after RT. In a meta-analysis 
published in 2014, local control rates provided by TLM applied 
in recurrent tumors after RT (56.9% in two years) were found 
to be lower compared to open partial laryngectomy (88.2% in 
two years) (35). This difference exists even after repeated TLMs 
(63.8% in two years). TLM is a moderately protective surgery 
with an average larynx preservation rate of 72.3%. This rate is 
84% in open partial surgeries (36). The low success rate in TLM, 
insufficient experience in open partial surgeries, and willingness 
to perform a complete oncologic surgery cause total laryngec-
tomy to be preferred in recurrent tumors after RT. However, 
in another meta-analysis published in 2015, TLM used in the 
recurrence of early glottic cancers treated with primary RT was 
reported to provide high rates of survival, local control, and or-
gan protection (37). The difficulty in the determination of cancer 
margins due to different forms of tumor growth, such as multi-
focal development and submucosal spread, which can be seen in 
recurrent tumors after RT, can decrease local control rates with 
TLM in recurrent laryngeal cancers. However, these are no lon-
ger the disadvantages with the use of frozen-section biopsies in 
surgery. In this manner, it is possible to remove the entire tumor 
with successive resections (38). In recent years, there are more 
studies reporting that total laryngectomy with TRS causes lower 
morbidity in recurrent cases after RT compared to open sur-
gery. Smith et al. (25) applied total laryngectomy with TRS in 
recurrent cases after chemoradiotherapy and concluded that it 
was more advantageous than open surgeries in terms of wound 
healing and fistula formation. They stated that the need for the 
application of a flap in the neck for the risk of fistula would be 
reduced in this manner.
Conclusion
Transoral laser microsurgery or transoral robotic surgery, which 
are options for minimal invasive surgical treatment, are increas-
ingly becoming more prominent in laryngeal surgery, because 
they give oncologically safe results and preserve the laryngeal 
functions to a great extent. However, further multicentered pro-
spective studies are needed for overcoming restrictive factors, 
such as still developing instruments, equipment and surgical 
experience, and for correctly interpreting the oncologic safety 
when commonly used in large patient series.
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